RAC 3.59% $1.59 race oncology ltd

RAC - Charts & Price Action, page-9822

  1. 11,249 Posts.
    lightbulb Created with Sketch. 29638
    There is an EU market which is also of interest to Big Pharma. An EU trial there will help the case for approval there but may need a follow up trial. We don’t have details yet on planned number of patients for an EU trial although planned spend implies a trial of reasonable size.

    5BF5BB64-9B1E-4825-80D6-217E03D8E005.jpeg
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.